Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_assertion type Assertion NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_head.
- NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_assertion description "[Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_provenance.
- NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_assertion evidence source_evidence_literature NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_provenance.
- NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_assertion SIO_000772 20406840 NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_provenance.
- NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_assertion wasDerivedFrom befree-2016 NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_provenance.
- NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_assertion wasGeneratedBy ECO_0000203 NP807183.RAYG1pEdKy8PGGaERkFKnZcZ4mv2kcISkgLXnAI571gBM130_provenance.